- About Us
- Contact Us
In addition to our expertise in biomarker discovery, bioinformatics and genomic services, we have extensive knowledge in:
We offer a full consultancy service and we will work with customers to find the solution for their requirements. We are the first company to approach the FDA with a FFPE based microarray test. We have experience of regulatory requirements and can also provide guidance in routes on regulatory approval.
We also have considerable expertise in using conventional generic microarrays for profiling FFPE tumors where a disease specific DSA® platform has not yet been developed.